BioCryst/$BCRX
About BioCryst
Ticker
Industry
Employees
BioCryst Metrics
$1.6B
-
-$0.60
1.89
-
Price and volume
Market cap
$1.6B
Beta
1.89
52-week high
$8.84
52-week low
$4.03
Average daily volume
1.9M
Financial strength
Current ratio
2.781
Quick ratio
2.621
Long term debt to equity
-172.069
Total debt to equity
-179.728
Interest coverage (TTM)
-0.35%
Management effectiveness
Return on assets (TTM)
-4.25%
Return on equity (TTM)
28.15%
Valuation
Price to revenue (TTM)
3.945
Price to book
-3.45
Price to tangible book (TTM)
-3.45
Price to free cash flow (TTM)
-28.689
Growth
Revenue change (TTM)
29.92%
Earnings per share change (TTM)
-51.87%
3-year revenue growth (CAGR)
53.52%
3-year earnings per share growth (CAGR)
-22.08%
What the Analysts think about BioCryst
Analyst Ratings
BioCryst Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
BioCryst Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
BioCryst News
BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)
BioCryst to Present at 43rd Annual J.P. Morgan Healthcare Conference
BioCryst Pharmaceuticals: Seasoned Blockbuster Makes It A Buy
FAQs
What’s the current market cap for BioCryst stock?
What is the P/E ratio for BioCryst stock?
Does BioCryst stock pay dividends?
No, BioCryst (BCRX) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next BioCryst dividend payment date?
BioCryst (BCRX) stock does not pay dividends to its shareholders.
What is the beta indicator for BioCryst?
BioCryst (BCRX) has a beta rating of 1.89. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.